Johnson Investment Counsel’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$521K Sell
21,914
-621
-3% -$14.8K ﹤0.01% 595
2026
Q1
$538K Buy
+22,535
New +$543K ﹤0.01% 563

Other funds holding IBD

Johnson Investment Counsel's IBD Position: Q2 2026 in Review

Johnson Investment Counsel reduced its Inspire Corporate Bond ETF (IBD) stake by 2.8% in Q2 2026, selling an estimated $14.8K and leaving 21,914 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #595.

Johnson Investment Counsel first reported a position in IBD in Q1 2026 and has held it in 2 quarters since. The position peaked at $538K in Q1 2026. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • Johnson Investment Counsel held 21,914 shares of Inspire Corporate Bond ETF worth $521K as of Q2 2026.
  • Johnson Investment Counsel sold 621 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $14.8K.
  • Inspire Corporate Bond ETF made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #595 holding.
  • Johnson Investment Counsel first reported a position in Inspire Corporate Bond ETF in Q1 2026 and has held it in 2 quarters since.
  • Johnson Investment Counsel's Inspire Corporate Bond ETF position peaked at $538K in Q1 2026.
  • 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.